Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL19639563

CC(C)ON(C(=N)N)c1ccccc1.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
HIF1A Q16665 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.34
ALOX5 P09917 1/20 0.34
MMP2 P08253 4/20 0.34
MMP9 P14780 4/20 0.34
MMP3 P08254 2/20 0.34
MMP8 P22894 2/20 0.34
MMP12 P39900 2/20 0.34
MMP13 P45452 2/20 0.34
MMP14 P50281 2/20 0.34
MMP16 P51512 2/20 0.34
IRAK4 Q9NWZ3 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
PLAU P00749 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL19639552 0.93 TSHR (0.35) LMNATSHRALOX5MMP2MMP9
Acetic Acid SCHEMBL19639567 0.89 TSHR (0.37) LMNATSHRALOX5IRAK4PDCD1
Oxalic Acid SCHEMBL19639580 0.89 TSHR (0.37) LMNAKDM4ETSHRALOX5MMP2
SCHEMBL19639527 0.89 KMT2A (0.37) LMNATSHRALOX5IRAK4PDCD1
SCHEMBL30500521 0.89 KMT2A (0.37) LMNATSHRALOX5IRAK4PDCD1
Methyl Alcohol SCHEMBL28857894 0.88 KMT2A (0.36) LMNATSHRALOX5IRAK4PDCD1
Fumaric Acid SCHEMBL19639547 0.85 HCAR2 (0.41) LMNAKDM4ETSHRALOX5IRAK4
Maleic Acid SCHEMBL19639577 0.85 HCAR2 (0.41) LMNAKDM4ETSHRALOX5IRAK4
Benzoic Acid SCHEMBL19639530 0.85 TSHR (0.41) LMNAKDM4ETSHRALOX5PDCD1
Sulfuric Acid SCHEMBL19639569 0.85 ESR1 (0.36) LMNAKDM4EMMP2MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342026-A1 ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342026-A1 ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED SUCNR1, SORD, BPGM LMNA 4339/4885HIF1A 368/4885KDM4E 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.